Speakers in alphabetical order


Prof. Achatz, Gernot (09.11.2010)
Universität Salzburg, Austria
„The Biology of IgE: Molecular Mechanisms Restraining Potentially Dangerous High Serum IgE Titres in vivo“

Prof. Alarcón, Balbino (18.05.2015)
Universidad Autónoma de Madrid, Spain
„Clustering, Conformational Changes and Cooperativity in the T-cell Receptor“

Prof. Alimonti, Andrea (10.01.2017)
Institute of Oncology Research, Bellinzona, Switzerland
„Reprogramming the tumor immune response for “pro-senescence” therapy for cancer“

Prof. Allman, David (09.10.2012)
Department of Pathology and Laboratory Medicine, University of Pennsylvania, USA
„Maintaining serum antibody responses“

Dr. Amigorena, Sebastian (11.01.2011)
INSERM U932 Immunité et Cancer, Institut Curie, Paris, France
„Antigen presentation and T cell activation by dendritic cells“

Dr. Clark, Andrew (30.07.2019)
Institut Curie, Paris, Frankreich
“Collective cell dynamics in intestinal cancer and homeostasis”

Prof. Ardavin, Carlos (11.06.2013)
Department of Immunology & Oncology, National Center for Biotechnology/CSIC, Madrid, Spain
„Production of type I interferon by inflammatory dendritic cells in response to Candida albicans infection“

PD Dr. Autenrieth, Stella (13.06.2017)
Universitätsklinikum Tübingen
„Modulation of dendritic cells by bacterial pathogens“


Barisch, Caroline (19.10.2010)
Universität Kassel
„Lipid Droplets in Dictyostelium discoideum – a proteomics approach“

Prof. Batinic-Haberle, Ines (11.12.2012)
Duke University, Durham, NC, USA
„The therapeutic effects of Mn porphyrins in radiation, cancer and central nervous system injuries“

Prof. Bäuerle, Patrick (21.06.2016)
MPM Capital, Cambridge Office
„T Cell-engaging Antibodies for Cancer Therapy“

Ph.D. Baumjohann, Dirk (14.04.2015)
Ludwig-Maximilians-Universität (LMU) München
„MicroRNA-mediated regulation of T helper cell differentiation and plasticity“

Prof. Bäumler, Andreas (02.07.2009)
University of California at Davis Department of Medical Microbiology and Immunology School of Medicine, USA
„Salmonella: life in the inflamed intestine“

Prof. Becher, Burkhard (25.11.2014)
University of Zurich, Institute of Experimental Immunology, Switzerland
„How T cells instruct myeloid cells in tissue inflammation!“

Dr. Bentzen, Amalie Kai (29.06.2021)
Section of Experimental & Translational Immunology, Dept Health Technology, Lyngby, Denmark
“Novel technologies for interrogating T-cell recognition”

Dr. Bergthaler, Andreas (01.06.2021)
Research Center for Molecular Medicine oft he Austrian Academy of Sciences, Vienna, Austria
“Viruses – Masters of Evolution and Immunometabolism”

Prof. Bischoff, Stephan (16.10.2018)
Institut für Ernährungsmedizin, Universität Hohenheim
“Intestinal barrier function in health and disease – from mouse to man”

Prof. Blankenstein, Thomas (01.06.2010)
Charité, Berlin
„The power of adoptive T cell therapy“

Prof. Bodenmiller, Bernd (19.01.2021)
Department of Quantitative Biomedicine, University of Zurich, Switzerland
“MASTer the defense: emerging roles of mast cells in innate and adaptive immunity”

PD Dr. Boernke, Frederik (29.01.2013)
Department of Biochemistry, Friedrich-Alexander-Universität
„Innate Immunity in Plants and its Subversion by bacterial Effectors“

Prof. Böhm, Thomas (10.02.2009)
Max-Planck-Institut für Immunbiologie Freiburg
„The evolutionary history of the thymus and the adaptive immune system“

Dr. Böttcher, Jan (26.05.2020)
Institute of Molecular Immunology and Experimental Oncology, Technische Universität München
“MASTer the defense: emerging roles of mast cells in innate and adaptive immunity”

Univ.-Prof. Bopp, Tobias (17.11.2015)
Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz
„Context- and Tissue-specific Regulation of Immunity and Tolerance by Protein Kinase CK2“

Prof. Borkhardt, Arndt (12.07.2011)
Universität Düsseldorf
„EBV-Associated Lymphproliferation Caused by Inherited, Primary T-Cell Deficiency“

Prof. Bozec, Aline (04.12.2012)
Medizinische Klinik 3, Universitätsklinikum Erlangen
„The multiple functions of Fra-2/ AP-1 transcription factor: from bone biology to metabolism and inflammation“

Prof. Brocker, Thomas (15.05.2012)
Institut für Immunologie, LMU München
„Dendritic cells and the induction of T cell tolerance“

Prof. Brocker, Thomas (20.10.2015)
Institute for Immunology, Ludwig-Maximilians-Universität Munich
„Tissue-specific control of immunity and tolerance by Dendritic Cells“

Prof. Brüne, Bernhard (12.11.2013)
Institut für Biochemie, Goethe-University Frankfurt
„Macrophages in the tumor microenvironment under the control of hypoxia and lipids“

Prof. Bulfone-Paus, Silvia (02.02.2010)
Leibniz-Zentrum Borstel
„Cellular and cytokine interactions in health and disease“

Prof. Busch, Dirk (26.10.2010)
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, TU München
„Primary T cells: A source for novel immunotherapies?“

Prof. Busch, Dirk (25.06.2013)
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, TU München
„Effector/memory CD8+ T cell differentiation at the single cell level“


Prof. Casanova, Jean-Laurent (28.03.2012)
The Rockefeller University, New York, USA
„Toward a genetic theory of infectious diseases“

Assoc. Prof. Christ, Daniel (26.06.2018)
Garvan Institute of Medical Research, Sydney, Australia
“Engineering antibody and T-cell specificity in vitro and in vivo”

Dr.Clark, Andrew (30.07.2019)
Institut Curie, Paris, Frankreich
“Collective cell dynamics in intestinal cancer and homeostasis”

Prof. Clatworthy, Menna (27.10.2020)
University of Cambridge, Department of Medicine, Molecular Immunity Unit, UK
“Tissue immunity in the kidney in homeostasis and autoimmunity”

Dr. Conrad, Marcus (18.12.2018)
Helmholtz Zentrum München
“Ferroptosis mechanisms in health and disease”

Prof. Crocker, Paul (06.12.2016)
School of Life Sciences, University of Dundee, UK
„Regulation of neutrophil and macrophage functions by the murine inhibitory lectin, Siglec-E“

Prof. Cursiefen, Claus (27.11.2018)
Zentrum für Augenheilkunde, Universität zu Köln
“Corneal lymphangiogenesis as model for transplant immunology and tumor metastasis”


Prof. Dalod, Marc (14.11.2017)
Centre d’Immunologie de Marseille Luminy, Marseille, Frankreich
“Deciphering how immune responses against infections or cancer are shaped by the cell types and states of mononuclear phagocytes”

Prof. Dalpke, Alexander (26.06.2012)
Dept. of Medical Microbiology and Hygiene, Heidelberg
„Lights on, lights off – signal induction and signal termination in innate immunity“

Prof. Decker, Thomas (30.06.2015)
„From Cosmos to Chaos-interferon signaling gets messy“

Prof. Dellabona, Paolo (14.05.2013)
San Raffaele Scientific Institute, Milano, Italy
„Targeting leukemia by CD1 autoreactive T cell responses“

Ph.D. den Haan, Joke (28.05.2015)
VU University Medical Cente, Amsterdam, The Netherlands
„CD169+ macrophages and dendritic cells: Collaboration results in efficient induction of adaptive immune responses“

Dr. Desel, Christiane (29.04.2009)
Max-Planck-Institut für Infektionsbiologie, Berlin
„Vaccination with recombinant (delta)ureC hly+ BCG induces a potent Th17 response“

Prof. Diefenbach, Andreas (25.10.2011)
Universitätsklinikum Freiburg
„Development and Function of Innate Lymphocytes“

Prof. Ivan Dikic (16.01.2018)
Institut für Biochemie II, Universtitätsklinikum Frankfurt
“Catalysis and Inhibition of Phosphoribosyl-dependent Ubiquitination”

Prof. Dittmer, Ulf (07.05.2013)
Institut für Virologie, Universität Duisburg-Essen
„The role of regulatory T cells in chronic viral infections“

Dr. Dorhoi, Anca (21.04.2015)
Max Planck Institute for Infection Biology Department of Immunology, Berlin
„The double-edged sword of inflammation in tuberculosis“

Prof. Dörner, Thomas (21.07.2009)
Bereich Klinische Hämostaseologie Charité Universitätsmedizin Berlin
„Direct and indirect targeting of B cells“

Prof. Dudeck, Anne (14.05.2019)
Institut für Molekulare und Klinische Immunologie, Otto-von-Guericke-Universität Magdeburg
“MASTer the defense: emerging roles of mast cells in innate and adaptive immunity”

Dr. Dunay, Ildiko (11.02.2014)
Universitätsklinikum Magdeburg
„Role of monocytes in Toxoplasma infection“

Prof. Dustin, Michael (14.04.2015)
Kennedy Institute, Oxford, UK
„Role of immunological synapse in T cell tolerance and priming“


Ph.D. Eberl, Gerard (06.11.2012)
Lymphoid Tissue Development Unit, Institut Pasteur, Paris, France
„Innate lymphoid cells and intestinal homeostasis“

Prof. Edinger, Matthias (27.07.2010)
Klinikum der Universität Regensburg
„Regulatory T cells in allogeneic stem cell transplantation“

Prof. Ehl, Stephan (08.07.2014)
CCI – Centrum für Chronische Immundefizienz, Universitätsklinikum Freiburg
„New lessons from human genetic disorders of T cell immunity“

Prof. Elewaut, Dirk (22.10.2013)
Division of Rheumatology, University of Ghent, Belgium
„Pathways leading to chronicity of disease in spondyloarthritis“

Prof. Enver, Tariq (31.01.2012)
University College London Cancer Institute, London, UK
„Title unknown“

Dr. Espéli, Marion (15.06.2021)
Inflammation Chemokines and Immunopathology, Institut National de la Santé et de la Recherche Medicale Paris, France
“SNARE-mediated regulation of plasma cell biology”

Esser-von Bieren, PhD, Julia (28.05.2019)
Center of Allergy & Environment (ZAUM), Technische Universität and Helmholtz Zentrum München
“Regulation of the arachidonic acid metabolism during type 2 immune responses”

Dr. Esterhazy, Daria (13.07.2021)
Department of Pathology The University of Chicago, IL, USA
“Duodenal control of pancreatic immunity through shared lymph node drainage”


Prof. Fasel, Nicolas (13.12.2016)
Center for Immunity and Infection, University of Lausanne, Switzerland
„Metastatic leishmaniasis“

Dr. Ferrazzi, Fulvia (08.04.2014)
Lehrstuhl für Humangenetik, Universitätsklinikum Erlangen
„Systems biology approaches to elucidate gene regulatory networks“

Prof. Feuerer, Markus (30.01.2018)
RCI Regensburger Centrum für Interventionelle Immunologie, Regensburg
“Tissular regulatory T cells”

Prof. Figdor, Carl (07.05.2019)
Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands
“21st century cancer vaccines”

Prof. Finke, Daniela (07.11.2017)
Universitäts-Kinderspital beider Basel, Schweiz
“License to operate – new insights into the regulation of ILC immune functions”

Prof. Fischer, Klaus-Dieter (23.10.2018)
Institut für Biochemie und Zellbiologie, Universitätsklinikum Magdeburg
“B cell migration and calcium: How MZBs migrate towards shear flow and how mature B cells remove calcium through only one extrusion pump”

Prof. Förster, Reinhold (19.01.2010)
Institut für Immunologie Medizinische Hochschule Hannover
„Die Bedeutung von sekundären und tertiären lymphatischen Organen für die Immunität in Respirationstrakt“

Prof. Förster, Reinhold (08.05.2018)
Institut für Immunologie Medizinische Hochschule Hannover
“Homing of immune cells via afferent lymphatics”

Prof. Förster, Irmgard (24.11.2015)
LIMES-Institut, Bonn
„Environmental control of immune responses through the AhR/AhRR sensory system“

Dr. Fröhlich, Anja (28.01.2014)
Charité Universitätsmedizin Berlin
„Cytokine-mediated regulation of antiviral CD8 T cell responses“

Ph.D. Fuchs, Tobias (26.04.2016)
Universitätsklinikum Hamburg-Eppendorf
„Neutrophil Extracellular Traps – A Link Between Inflammation And Thrombosis“


Prof. Gagliani, Nicola (24.04.2018)
General, Visceral and Thoracic Surgery Department, University Medical Center Hamburg-Eppendorf
“T cell functional heterogeneity and tissue-resident memory cells: understanding immune homeostasis and its underlying mechanisms”

Prof. Galon, Jérôme (18.05.2010)
Cordeliers Research Center, Paris, France
„Intratumoral immune reaction: a novel paradigm for colorectal cancer“

Gärtner, Florian MD, PhD (06.11.2018)
Medizinische Klinik und Poliklinik I, LMU München
“Platelets on the move – boosters of innate immunity”

Dr. Gasteiger, Georg (21.01.2014)
Memorial Sloan-Kettering Cancer Center, New York, USA
„Help and Regulation: Interactions of adaptive and innate lymphocytes“

Ph.D. Geijtenbeek, Teunis (12.05.2009)
VU University Medical Center Amsterdam, Molecular Cell Biology and Immunology, The Netherlands
„C-type lectin signalling in adaptive immunity and infections“

Prof. Ghosh, Sankar (23.02.2015)
Columbia University, NY, USA
„Regulation of NF-kB in inflammation and Immunity“

Dr. Glocker, Erik (18.01.2011)
Royal Free Hospital and University College Medical School, London, UK
„Monogenic causes for early-onset inflammatory bowel disease“

Prof. Gottlieb, Eyal (10.07.2018)
Technion – Israel Institute of Technology, Haifa, Israel
“Identifying and exploiting cancer’s metabolic liabilities”

Prof. Gramberg, Thomas (08.11.2011)
Institut für Virologie, Universitätsklinikum Erlangen
„SIV Vpx protects divergent retroviruses from a SAMHD-1 mediated restriction in macrophages“

Prof. Granucci, Francesca (07.02.2012)
Department of Biotechnology and Bioscience, University of Milano-Bicocca, Italy
„The Multifaceted Roles of CD14 in Innate Immunity“

Prof. Graßl, Guntram (10.11.2020)
Medizinische Hochschule Hannover, Institut für Medizinische Mikrobiologie und Krankenhaushygiene
“Role of host glycans for the susceptibility to infections with enteric pathogens”

Dr. Gray, Mohini (28.04.2015)
The Queen’s Medical Research Institute, Edinburgh, UK
„Immune Tolerance to Apoptotic cells is mediated by Self Reactive Innate-Like B cells“

Prof. Gregory, Christopher (29.11.2011)
MRC Centre for Inflammation Research, Edinburgh, UK
„The Role of Apoptosis in Conditioning the Microenvironment of Tumours“

Dr. Greiff, Victor (16.06.2020)
University of Oslo, Department of Immunology, Oslo, Norwegen
“Quantifying the specificity of the adaptive immune response on the repertoire and sequence level”

PD Dr. Greten, Florian (09.06.2009)
Technische Universität München, 2. Medizinische Klinik, Klinikum rechts der Isar
„NF-kappaB and Stat3 –from inflammation to colon cancer“

Prof. Greten, Florian (18.11.2014)
Georg-Speyer-Haus, Institut für Tumorbiologie und experimentelle Therapie, Frankfurt a. M.
„NF-kappaB and Stat3 control cell plasticity in intestinal tumorigenesis“

Prof. Groettrup, Marcus (04.02.2014)
Institut für Immunologie, Konstanz
„The immunoproteasome in the pathogenesis of autoimmune diseases“

Prof. Gunzer, Matthias (17.11.2020)
Institut für Experimentelle Immunologie und Bildgebung, Universität Duisburg-Essen
“The impact of inflammation on the mobilization and tissue homing of neutrophils”


Prof. Haas, Rainer (23.06.2009)
Max-von-Pettenkofer-Institut für Hygiene und medizinische Mikrobiologie, München
„Helicobacter pylori, a paradigm for chronic infection and modulation of the host“

Prof. Hackstein, Holger (30.04.2019)
Transfusionsmedizinische und Hämostaseologische Abteilung in der Chirurgischen Klinik, Uniklinikum Erlangen
“ADAR1 and dendritic cells”

Dr. Häberlein, Simone (08.10.2015)
Leiden University Medical Center, Leiden, The Netherlands
„A “worm pill” against asthma? Induction of regulatory B cells by helminth antigens and their application in experimental allergic asthma therapy“

Prof. Haller, Otto (24.05.2011)
University of Freiburg
„Innate Immunity to Influenza Viruses“

Prof. Hamann, Alf (08.02.2011)
Dt. Rheumaforschungszentrum, Berlin
„Epigenetic imprinting of T cell homing and function“

Ph.D. Hammad, Hamida (19.05.2009)
University Ghent Department of Internal Medicine, Belgium
„Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma“

Prof. Hämmerling, Günter (16.06.2009)
Deutsches Krebsforschungszentrum DKFZ Abt. Molekulare Immunologie, Heidelberg
„Feedback control of dendritic cell homeostasis, and consequences for intrinsic T cell reactivity“

Prof. Hammerschmidt, Sven (08.01.2019)
Department of Molecular Genetics and Infection Biology, Universität Greifswald
“Function and immunogenicity of Streptococcus pneumoniae surface proteins”

Prof. Harris, Nicola (25.10.2016)
École polytechnique fédérale de Lausanne, Switzerland
„The multifaceted roles of B cells in helminth immunity“

Prof. Hauber, Joachim (22.01.2019)
Heinrich-Pette-Institut, Leibniz-Institut für Experimentelle Virologie, Hamburg
„Antiviral Therapy of Persistent Viral Infection using Genome Editing”

Prof. Hayday, Adrian (10.07.2012)
Immunology, Infection and Inflammatory Disease King´s College London, UK
„Lymphoid stress-surveillance: the benefits and challenges of useful autoimmunity“

Dr. rer. nat. Helming, Laura (28.04.2009)
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene TU München
„Multinucleated giant cells and osteoclasts: The molecular basis of macrophage fusion“

Prof. Henneke, Philipp (08.06.2021)
Center for Chronic Immunodeficiency, University Medical Center Freiburg
“Cytomegalovirus subverts macrophage identity”

Prof. Herr, Wolfgang (24.11.2009)
Universitätsklinikum Mainz
„Separation GVHD-GVL by adding GVL-mediating T cells“

Prof. Hidalgo, Andrés (27.10.2015)
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
„Functional interactions of neutrophils with the bone marrow“

Prof. Hiepe, Falk (10.11.2009)
Charite Berlin
„Memory plasma cells in autoimmunity“

Prof. Hildeman, David (22.10.2019)
Cincinnati Children’s Hospital Medical Center
“A novel Tfh population accumulates with age and links inflammation with age-related immune suppression”

Prof. Hoebe, Kasper (25.01.2011)
Cincinnati Children’s Hospital, OH, USA
„Understanding the genetic basis of immune deficiencies: a small scale ENU mutagenesis approach“

Ph.D. Hofreuter, Dirk (08.04.2009)
Yale University School of Medicine Boyer Center for Molecular Medicine, New Haven, USA
„Metabolic diversity in Campylobacter jejuni influences tissue tropism during infection“

Univ.-Prof. Hornef, Mathias (09.05.2017)
Institut für Medizinische Mikrobiologie, Universitätsklinik der RWTH Aachen
„Ontogeny of the intestinal mucosal host response to infection“

Prof. Hünig, Thomas (19.06.2012)
Lehrstuhl für Immunologie, Universität Würzburg
„Oligodendrocytes enforce immune privilege of the non-infected brain by deleting the peripheral CD8 T-cell repertoire of auto-reactive cells“

Dr. Hutloff, Andreas (03.12.2019)
Chronische Immunreaktionen, Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
“T cell / B cell interactions in chronically inflamed tissues”


Prof. Jahnen-Dechent, Willi (27.10.2009)
Universität Aachen
„Bugs, dead cells, blood clots, mineral and lipid: Fetuin family-serum proteins play vital roles in cellular remodelling and systemic clearing of debris“

Prof. Jonjić, Stipan (02.07.2013)
Department for Histology and Embryology, University of Rijeka, Croatia
„Expression of NKG2D ligand RAE-1 by mouse cytomegalovirus enhances virus immunogenicity and vaccine efficacy“

Dr. Jonuleit, Helmut (19.01.2016)
Department of Dermatology, Johannes Gutenberg-University Mainz
„IL-6 modifies immunoregulation of T cell responses in Multiple Sclerosis“

Prof. Jung, Steffen (05.12.2017)
Weizmann Institute of Science, Rehovot, Israel
“Macrophage strategies in gut and brain”


Dr. Kaminski, Marcin (07.01.2014)
DKFZ Heidelberg
„Mitochondrial oxidative signaling in T cell activation: role for Warburg effect and a new ADP-dependent glucokinase“

Prof. Karin, Michael (12.04.2011)
University of California, San Diego, CA, USA
„Control of Tumor Progression and Metastasis by Lymphocyte-Produced Cytokines“

Prof. Kastenmüller, Wolfgang (24.06.2014)
Institutes of Molecular Medicine and Experimental Immunology (IMMEI), University of Bonn
„Pathogen Defense in the Lymph Node – From Innate to Adaptive Immunity“

Prof. Kastenmüller, Wolfgang (15.05.2018)
Institute of Experimental Immunology (IEI), University of Würzburg
“Concepts of T cell activation from a spatiotemporal perspective”

Prof. Klein, Ludger (13.11.2012)
Institute for Immunology, Ludwig-Maximilians-Universität München
„Thymic epithelium and central T cell tolerance“

Dr. Klose, Christoph (04.02.2020)
Charité – Universitätsmedizin Berlin
“Immune regulation at barrier surfaces by group 2 innate lymphoid cells”

Dr. Koch, Manuel (08.12.2015)
Max Planck Institute for Infection Biology, Berlin
„The role of Helicobacter pylori in the development of gastric adenocarcinoma“

Prof. Köhl, Jörg (15.10.2019)
Institute for Systemic Inflammation Research, Universität zu Lübeck
“Non-canonical functions of complement in inflammatory diseases”

Prof. Kopf, Manfred (06.05.2014)
Institute of Molecular Health Sciences ETH Zürich, Switzerland
„Alveolar Macrophage Development and Function in Respiratory Viral Infection“

Prof. Korn, Thomas (28.06.2011)
Klinikum rechts der Isar Technische Universität München
„T Cellular Players in Autoimmune Neuroinflammation“

Prof. Körner, Heinrich (28.10.2014)
Menzies Research Institute Tasmania, Australia
„A New Function For An Old Acquaintance? Dissecting the Roles of TNF in Monocyte Differentiation.“

Prof. Koszinowski, Ulrich (02.11.2010)
Max von Pettenkofer-Institut, Virologie, LMU München
„Much ado about almost nothing: A random approach to herpesvirus morphogenesis“

Ph.D. Kovarik, Pavel (20.03.2009)
Max F. Perutz Laboratories University of Vienna, Austria
„RNA decay in immune Homeostasis“

Dr. Kremer, Anita (16.04.2013)
Medizinische Klinik 5, Universitätsklinikum Erlangen
„HLA class II restricted minor histocompatibility antigens in graft-versus-leukemia effect and graft-versus-host disease“

Prof. Kreutz, Marina (12.04.2016)
University Hospital Regensburg
„Immunomodulation by lactic acid“

Ph.D. Kriegel, Martin (12.07.2016)
Yale School of Medicine, New Haven, USA
„T and B Cell Cross-reactivity in the Human Autoimmune Microbiome“

Prof. Krönke, Martin (22.06.2010)
Universität Köln
„TNF Signaling and Regulation of ROS Production“

Prof Krüger, Elke (26.11.2013)
Charité Universitätsmedizin Berlin, Institute of Biochemistry
„The ubiquitin proteasome system at the crossroads of oxidative stress and immune responses“

Prof. Kurzai, Oliver (23.06.2015)
Leibniz-Institute for Natural Products Research and Infection Biology – Hans-Knoell-Institute, Jena
„The role of neutrophils in invasive fungal infections“


Prof. Lachmann, Nico (24.11.2020)
Medizinische Hochschule Hannover
Klinik für Pädiatrische Pneumologie, Allergologie und Neonatologie
“Stem Cells and Macrophages: New Therapeutic Approaches”

Dr. Lämmermann, Tim (05.11.2019)
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE)
“Navigation and communication strategies of innate immune cells in inflamed and infected tissues”

Prof. Landau, Nathaniel (14.01.2014)
Department of Microbiology, New York, USA
„Restriction of HIV-1 by SAMHD1: Starving the Virus“

Prof. Latz, Eicke (15.11.2011)
Institute of Innate Immunity, University Hospital University Bonn
„Mechanisms of Inflammasome Activation in Inflammatory Diseases“

Prof. Lee, James (18.10.2016)
Mayo Clinic, Scottsdale, Arizona, USA
„Eosinophils in Health and Disease: Regulators of Local Tissue Immune Responses”

Dr. Lehuen, Agnès (16.10.2012)
Institut National de la Santé et de la Recherche Médicale, L’Université Paris–Descartes, France
„Regulatory role of NKT cells in viral infection and autoimmune diabetes“

Prof. LeibundGut-Landmann, Salomé (09.12.2014)
Institute of Microbiology, ETH Zürich, Switzerland
„Interleukin-17-mediated host defense against fungal infection“

Dr. Lennon-Duménil, Ana Maria (04.05.2010)
Institut Curie, Paris, Framce
„Spatio-temporal Regulation of Antigen Presentation and Dendritic Cell Migration“

Prof. Leverkus, Martin (03.07.2012)
Klinik für Dermatologie, Venerologie und Allergologie, Universität Heidelberg
„The Ripoptosome, a novel signalling platform regulating apoptosis and necroptosis“

Dr. Lindestam Arlehamn, Cecilia (18. 05 2021)
La Jolla Institute for Immunology, La Jolla, CA
“Autoimmunity and the role of T cells in Parkinson’s disease”

Prof. Linington, Christopher (21.01.2020)
Institute of Infection, Immunity & Inflammation, University of Glasgow, UK
“Antibody-mediated activation of microglia: a generalised treatment strategy for viral encephalitis”

Dr. Linker, Ralf (18.12.2012)
Universitätsklinikum Erlangen
„New insights into disease mechanisms in MS: on the way to translational medicine“

Prof. Locati, Massimo (08.06.2010)
University of Milan, Italy
„Macrophage polarized activation: lessons from transcriptional profiling“

Prof. Löhning, Max (20.12.2011)
DRFZ Berlin
„Generation, maintenance and reprogramming of immunological memory“

Univ.-Prof. Lüdde, Tom (22.11.2016)
Universitätsklinikum RWTH Aachen
„Programmed Cell Death Pathways in Liver Disease and Hepatokarzinogenesis“

Prof. Ludewig, Burkhard (23.01.2018)
Institut für Immunbiologie, Kantonspital St. Gallen, Schweiz
“Stromal cell – innate lymphoid cell interaction”

PD Dr. Ludwig-Portugall, Isis  (29.01.2019)
Institut für experimentelle Immunologie (IEI), Uniklinik Bonn
“Innate lymphocytes (ILCs) respond to crystal-deposition and promote local inflammation and fibrosis”

Prof. Lutz, Manfred (22.01.2013)
Institute of Virology and Immunobiology, Julius-Maximilians-Universität Würzburg
„Myeloid-Derived Suppressor Cell function shaped by GM-CSF licensing and mycobacterial activation“


Prof. MacDonald, Andrew (05.06.2018)
Manchester Collaborative Centre for Inflammation Research (MCCIR), University of Manchester, UK
“Dendritic cells and macrophages in promotion and regulation of Type 2 inflammation”

Prof. Mackenzie, Ian (30.04.2013)
Barts and The London School of Medicine and Dentistry, London, UK
„Phenotypic switching of stem cells in head and neck cancers“

Prof. Macpherson, Andrew (09.06.2015)
Gastroenterology & Mucosal Immunology, Inselspital Bern, Switzerland
„When and where are our bodies influenced by our intestinal microbes?“

Ph.D. Magali, Irla (06.07.2021)
Centre d’Immunologie de Marseille-Luminy  (CIML), Marseille, France
“Lymphotoxin, a novel immune checkpoint of Treg suppressive activity”

Prof. Maizels, Rick (23.10.2012)
Institute of Immunology and Infection Research, University of Edinburgh, UK
„Immune regulation by helminths : impact on allergy and immunity“

Prof. Malissen, Bernard (03.05.2011)
Marseille, France
„Disentangling the complexity of the dendritic cell networks present in the skin and the thymus“

Prof. Mandelboim, Ofer (17.01.2012)
Hebrew University Hadassah Medical School, Israel
„Proteins and miRNA-mediated Regulation of NK Cell Activity“

Prof. Manz, Markus (09.07.2013)
Experimental Hematology Lab, University Hospital Zurich, Switzerland
„Hematopoietic Homeostasis in Steady-State and Inflammation“

Prof. Marshall, Aaron (11.11.2013)
Departments of Immunology, Biochemistry and Medical Genetics, University of Manitoba, Canada
„Phosphoinositide signaling pathways in B lymphocytes“

Ph.D. Martins, Vera (01.07.2014)
Institute for Immunology, University Hospital Ulm
„Cell competition is a tumor suppressor mechanism in the thymus“

Dr. Mass, Elvira (12.11.2019)
Lehrstuhl für Genetik, Department Biologie, FAU
“Dissecting myeloid cell biology – from development to disease”

Dr. Mayer, Johannes (12.01.2021)
Malaghan Institute of Medical Research, Wellington, New Zealand
“Development of functional Th2-promoting dendritic cell subsets in naïve skin requires innate IL-13”

Prof. McKeating, Jane (06.07.2010)
University of Birmingham, UK
„The ins and outs of hepatitis C virus“

Prof. McKenzie, Andrew (25.02.2014)
Cambridge Biomedical Campus, Cambridge, UK
„Type-2 innate lymphoid cells (ILC2) in infection and allergy“

McLellan, PhD, Jason (02.06.2020)
The University of Texas at Austin, TX, USA
“Development of Vaccines and Nanobodies for SARS-CoV-2”

Prof. Meinl, Edgar (27.04.2010)
MPI München
„Humoral immunity in Multiple Sclerosis“

Prof. Melero, Ignacio (08.05.2012)
University of Navarra, Pamplona, Spain
„Immunostimulatory monoclonal antibodies directed to CD137“

Prof. Mellor, Andrew (12.12.2017)
Institute of Cellular Medicine, Newcastle University, UK
“Exploiting DNA as an immune adjuvant to treat cancer & autoimmune syndromes”

Dr. Mercer, Jason (08.12.2009)
Institut für Biochemie Zürich, Switzerland
„High-throughput Screening of Troy: In search of the Achilles’ heel of Poxvirus Infection“

Prof. Miller, Jacques (14.10.2016)
Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
„Thymus function revealed“

Prof. Moser, Muriel (13.07.2010)
Université Libre de Bruxelles, Belgium
„Control of T helper cell development by regulatory T cells in vivo“

Prof. Müller, Andreas (29.05.2018)
Institute of Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg
“In vivo biosensors for functional analysis of host-pathogen interaction dynamics”

Prof. Münz, Christian (27.06.2017)
Institute of Experimental Immunology, University of Zürich, Schweiz
„Infection and immune control of human tumor viruses in vivo“

Prof. Murphy, Kenneth (12.12.2011)
Washington University, St. Louis, MO, USA
„Batf factors in immune function“

Dr. Murray, Peter (20.10.2014)
St. Jude Children’s Research Hospital, Memphis, USA
„Amino acid metabolism links immunoregulation and immune pathology“


Prof. Nagy, Laszlo (15.12.2009)
Universität Debrecen, Hungary
„Nuclear hormone receptors link lipid metabolism and immune function in macrophages and dendritic cells“

Prof. Nagy, László (15.06.2010)
Universität Debrecen, Hungary
„Nuclear hormone receptors link lipid metabolism and immune function in macrophages and dendritic cells“

Prof. Nathan, Carl (03.11.2009)
Cornell University New York, NY, USA
„Chemotherapy of Infectious Disease Guided by Host-Pathogen Interactions“

Dr. Neukomm, Lukas (09.03.2010)
University of Zurich, Institute of Molecular Biology, Switzerland
„Regulation of cell corpse removal – a worm´s point of view“


Okkenhaug, Klaus (02.03.2010)
Babraham Institute Cambridge, UK
„Role of PI3K in immunity and inflammation“

Prof. Olins, Donald and Ada (05.02.2013)
University of New England, Maine, USA
„The Deformable Granulocyte Nucleus and Epichromatin“


Prof. Pabst, Oliver (05.06.2012)
Medizinische Hochschule Hannover
„Generating IgA Repertoire Diversity in the Intestine“

Prof. Pabst, Oliver (26.11.2019)
Institut für Molekulare Medizin, Universitätsklinikum RWTH Aachen
“Modulation of adaptive immunity by the gut microbiota”

Prof. Pasparakis, Manolis (22.11.2011)
Universität zu Köln
„Epithelial Regulation of Intestinal Inflammation and Cancer“

Prof. Pearce, Edward (03.05.2016)
Max-Planck-Institut für Immunbiologie und Epigenetik, Freiburg
„Metabolic reprogramming in innate immune cell activation“

Prof. Peipp, Matthias (17.01.2017)
Sektion für Stammzell- und Immuntherapie, Christian-Albrechts-Universität zu Kiel
„Antibody Engineering to Improve Immunotherapy of Cancer“

Prof. Pinschewer, Daniel (13.11.2018)
Departement Biomedizin, Universität Basel, Schweiz
“Humoral immune defense in persistent viral infection”

Prof. Pircher, Hanspeter (18.07.2017)
Institute for Immunology, University Medical Center Freiburg
„Antibodies and tissue-resident memory T cells in LCMV infection“

Prof. Pockley, Graham (17.07.2012)
Immunobiology Research Group, Department of Oncology, University of Sheffield, UK
„The contrasting immunoregulatory properties of heat shock proteins and their influence on disease processes and therapeutic potential“

Prof. Pogge von Strandmann, Elke (22.12.2009)
Labor für Immuntherapie Klinik I für Innere Medizin Universität zu Köln
„Stress inducible ligands and NK cell activation“

Dr. Portugal, Silvia (07.01.2020)
Department of Infectious Diseases, Parasitology, Heidelberg University Hospital
“Plasmodium falciparum dry season reservoir: a long hide and seek game”

PD Dr. Prinz, Immo (20.03.2012)
Medizinische Hochschule Hannover
„Is there a role for innate or adaptive gamma/delta T lymphocytes in the immune response to cytomegalovirus?“

PD Dr. Probst, Hans Christian (20.01.2015)
Johannes Gutenberg University Mainz
„Tolerogenic Dendritic Cells: Bridging dominant and cell autonomous mechanisms of peripheral tolerance“


Dr. Isaak Quast (11.05.2021)
Department of Immunology & Pathology, Monash University, Melbourne, Australia
„Maintaining germinal centre homeostasis: From ubiquitous response amplification to affinity-based selection“


Prof. Randow, Felix (20.05.2014)
MRC Laboratory of Molecular Biology, Cambridge, UK
„Autophagy in host-pathogen interactions“

Prof. Reddy, Sai (17.06.2014)
ETH Zürich, Technology Department of Biosystems Science & Engineering, Basel, Switzerland
„Applying systems immunology for the analysis of B cells and antibody repertoires“

Dr. Reed, Joanne (25.06.2018)
Garvan Institute of Medical Research, Sydney, Australia
“Single cell analysis of self-reactive B cells in Autoimmune Disease”

Reis e Sousa, Caetano (01.02.2011)
Cancer Research UK, London, UK
„Innate regulation of adaptive immunity by dendritic cells“

Dr. Rhodes, Benjamin (10.01.2012)
King’s College London, UK
„SLE genetics – lots of genes but what next?“

PD Dr. Rizzi, Marta (14.01.2020)
Klinik für Rheumatologie und Klinische Immunologie, Universitätsklinikum Freiburg
“To B or not to B: developmental decisions in human B cells”

Prof. Roers, Axel (15.10.2013)
Institut für Immunologie, TU Dresden
„Mouse models for Aicardi-Goutières syndrome: Does the innate response to endogenous retroelements cause autoimmunity?“

Dr. Romagnani, Chiara (26.01.2016)
Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin
„Adaptive traits of NKG2C+ NK cell expansions in HCMV seropositive individuals“

Prof. Romani, Luigina (17.02.2009)
Department of Experimental Medicine University of Perugia, Italy
„Tryptophane metabolism and immune response“

Prof. Romani, Luigina (09.02.2010)
Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Universität Perugia, Italy
„The Immunology of fungi: the story so far“

Prof. Romani, Nikolaus (10.12.2013)
Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Innsbruck, Austria
„Langerhans cells & more: attempts to harness their immunological functions“

Prof. Rösch, Alexander (02.12.2014)
Universitätsklinikum Essen
„The cancer stem cell controversy and phenotypic plasticity in melanoma: Implications for the clinics“

Prof. Rosenstiel, Philip  (05.01.2019)
Institut für Klinische Molekularbiologie, Christian-Albrechts-Universität zu Kiel
„Mechanisms of homeostasis at the intestinal barrier“

Prof. Dr. Rudel, Thomas (05.05.2009)
Lehrstuhl für Mikrobiologie, Theodor-Boveri-Institut für Biowissenschaften, Universität Würzburg
„Bacterial infection targeting the host cell death machinery“

Prof. Rudolph, Lenhard (19.04.2016)
Leibniz-Institut für Alternsforschung – Fritz-Lipmann-Institut e.V. (FLI)
„Hematopoietic Stem Cell Aging and Lymphopoiesis“

Prof. Rupp, Jan (27.05.2014)
Med. Mikrobiologie und Hygiene, Med. Klinik III, Lübeck
„Interplay between hypoxia/HIF-1 related signaling with metabolic and inflammatory reactions in intracellular chlamydial infections“


Prof. Sallusto, Federica (31.05.2011)
Institute for Research in Biomedicine, Bellinzona, Switzerland
„Dendritic cells and the demanding task of priming T cell responses“

Ph.D. Sancho, David (13.01.2015)
CNIC- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain
„Novel aspects on Regulation of Th1 immunity by Dendritic cells“

Univ.-Prof. Sawitzki, Birgit (30.10.2018)
Charité – Universitätsmedizin Berlin, Institut für Medizinische Immunologie
“Expression pattern and control by inhibitory receptors of T helper cell subsets”

PD Dr. Schabbauer, Gernot (31.01.2017)
Institute of Physiology, Medical University of Vienna, Austria
„PI3K and PTEN at the interface of innate and adaptive immunity“

Prof. Schaible, Ulrich (25.06.2019)
Forschungszentrum Borstel,
Leibniz Lungenzentrum
“Host-directed therapy approaches in tuberculosis”

Prof. Schäkel, Knut (15.11.2016)
Universitäts-Hautklinik, Heidelberg
„Identity and pro-inflammatory function of human 6-sulfo LacNAc (slan) dendritic cells“

Prof. Schendel, Dolores (27.11.2012)
Helmholtz Zentrum München, Institut für Molekulare Immunologie
„Selection and use of high-affinity T cell receptors in designer lymphocytes for adoptive cell therapy“

Prof. Schuppan, Detlef (20.11.2018)
Institut für Translationale Immunologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz
„Nutrition and Autoimmunity: Wheat, ATI and Inflammation“

Prof. Schild, Hansjörg (16.11.2010)
Universität Mainz
„CD4 positive T cell subpopulations in the induction and control of adaptive immunity“

Dr. Schlitzer, Andreas (10.05.2016)
LIMES-Institute, University of Bonn
„Redefining Dendritic cell development – one cell at a time“

Prof. Schmeck, Bernd (29.11.2016)
Philipps-Universität Marburg, Klinik für Pneumologie
„Modeling RNA-networks in host-pathogen interaction“

Prof. Schmidt-Supprian, Marc (15.12.2015)
Technische Universität München
„NF-kB activation in Autoimmunity and Lymphomagenesis“

Prof. Schmitz, Gerd (27.01.2009)
Universitätsklinikum Regensburg
„The Lipom“

Dr. Schober, Kilian (02.08.2019)
Institut für medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München
„Re-directing T cells through advanced genetic engineering of T cell receptors for therapy“

Prof. Schöler, Hans (04.07.2011)
MPI für molekulare Biomedizin, Münster
„Induction of Pluripotency: 20 Years of Research“

Prof. Schröder, Jens-Michael (30.06.2009)
Klinik für Dermatologie, Venerologie und Allergologie, Kiel
„Antimicrobial Peptides: Effector Molecules of the Local Host Defense System“

Prof. Schüler, Thomas (05.07.2011)
Charité Berlin
„The Regulation of Intestinal Homeostasis by Interleukin-7“

Prof. Schultze, Joachim (13.05.2014)
LIMES Institute, Genomics and Immunoregulation, Bonn
„The spectrum of macrophage activation. Beyond the M1/M2 model“

Prof. Schulz, Christian (23.05.2017)
Klinikum der Universität München, Ludwig-Maximilians-Universität München
„Macrophage development – does origin matter?“

Prof. Schumacher, Ton (29.06.2010)
The Netherlands Cancer Institute, Amsterdam, The Netherlands
„Dissecting and manipulating tumor-specific T cell immunity“

Prof. Schuppan, Detlef (20.11.2018)
Institut für Translationale Immunologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz
„Nutrition and Autoimmunity: Wheat, ATI and Inflammation“

Dr. Segura, Elodie (28.01.2020)
INSERM, Institut Curie, Centre d’Immunothérapie, Paris, France
“Functional specialization of human dendritic cell subsets”

Prof. Sexl, Veronika (15.01.2013)
Veterinärmedizinische Universität Wien, Austria
„Nk cell dependent tumor surveillance – STATs in the spotlight“

Dr. Shakhar, Guy (14.10.2013)
Department of Immunology, Weizman Institute of Science, Revohot, Israel
„Insights from live 2-photon imaging of tumors: Angiogenesis promotes CTL dissemination and cytotoxicity“

Dr. Sheriff, Ahmed (20.10.2009)
Charite Berlin
„CRP as a therapeutic target: cardiac infarction therapy in pigs“

Prof. Sieweke, Michael (17.10.2017)
Centre d’Immunologie de Marseille Luminy, Marseille, Frankreich
“Stem cell like mechanisms of macrophage self renewal”

Prof. Silva-Santos, Bruno (26.01.2021)
Instituto de Medicina Molecular, Universidade de Lisboa, Portugal
“Functional and metabolic dichotomy of effector gamma-delta T cell subsets”

Dr. Sinclair, Linda (28.04.2020)
Division of Cell Signalling and Immunology , School of Life Sciences, University of Dundee, UK
“Nutrient transport in T cells”

Prof. Sixt, Michael (06.12.2011)
Institute of Science and Technology Austria, Klosterneuburg
„Mechanisms of Leukocyte Chemotaxis“

Prof. Sparwasser, Tim (17.11.2009)
TWINCORE GmbH Zentrum für Experimentelle und Klinische Infektionsforschung, Hannover
„Novel approaches for vaccine design: Bypassing Treg activity enhances T cell-mediated immunity“

Prof. Spits, Hergen (30.06.2020)
Amsterdam Infection & Immunity Institute, Amsterdam, Niederlande
“Development, function and plasticity of Human ILC2″

Prof. Staege, Martin (20.06.2017)
Universitätsklinikum Halle (Saale)
„Gene Expression Music applications in immunology and cancer research“

Dr. Stecher, Bärbel (04.03.2009)
Institut für Mikrobiologie, Eidgenössische Technische Hochschule (ETH) Zürich, Switzerland
„The gut flora and infections with enteropathogenic bacteria“

Prof. Stenger, Steffen (21.06.2011)
Universität Ulm
„Effector Mechanisms in Immunity to Tuberculosis in Humans“

Prof. Stockinger, Brigitta (06.02.2014)
National Institute for Medical Research, London, UK
„Environmental triggers of inflammatory immune responses“

Dr. Stoitzner, Patrizia (08.05.2014)
Department of Dermatology & Venereology, Innsbruck Medical University, Austria
„Skin dendritic cells in tumor immunity: interesting targets for immunotherapy?“

Ph.D. Streeck,, Hendrik (16.06.2015)
HIV Diagnostics and Reference Laboratory, Silver Spring, USA, ab Juni am Uniklinikum Essen
„B cell and Tfh dynamics in HIV pathogenesis and vaccination“

Prof. Strieter, Robert (24.01.2012)
University of Virginia, Charlottesville, USA
„The role of CXC chemokines in Lung Cancer“

Prof. Strober, Warren (12.05.2015)
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA
„The Role of E-Proteins in Th17 and Regulatory T cell induction“

Dr. Strowig, Till (27.01.2015)
Helmholtz Center for Infection Research, Braunschweig
„Living on the edge – The intestinal microbiota and local inflammatory responses“

Prof. Strowig, Till (02.07.2019)
Dept. of Microbial Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig
“Investigating the interplay of microbiota and host: From bugs to phenotypes”

Ph.D. Swirski, Filip (12.01.2016)
Harvard Medical School, Boston, USA
„Growth factors link B cells with macrophages in inflammation and metabolism“


Prof. Tang, Christopher (13.01.2009)
Imperial College London, UK
„Generic mechanisms in Neisseiria meningitidis for Immune escape“

Prof. Tenbusch, Matthias (02.05.2017)
Klinische und Molekulare Virologie, Universitätsklinikum Erlangen, FAU
„Gene-based vaccines against respiratory tract infections“

Prof. Thelen, Marcus (07.07.2015)
Università della Svizzera italiana, Institute for Research in Biomedicine, Bellinzona, Switzerland
„ACKR3 (CXCR7): role in B cell responses“

PD Dr. Titze, Jens (26.07.2011)
IZKF Nachwuchsgruppe II, Universität Erlangen
„Macrophages Are Essential for Electrolyte and Blood Pressure Homeostasis“

Prof. Titze, Jens (11.09.2018)
Medizinische Klinik 4, UK Erlangen, Duke-National University of Singapore, Duke University Medical Center, Durham, USA
“Using immune cells to understand salt and water metabolism”

Prof. Trepel, Martin (08.01.2013)
Universitätsklinikum Hamburg-Eppendorf
„Characterization and targeting of cell-type-specific receptors in cancer and normal tissues.“

Dr. Triantafyllopoulou, Antigoni  (17.04.2018)
Department of Rheumatology and Clinical Immunology, Charité – University Medical Centre Berlin
“DNA damage signals instruct macrophage differentiation in granulomatous diseases”

Prof. Trkola, Alexandra (24.05.2016)
Institut für Medizinische Virologie, Universität Zürich, Schweiz
„Virus, Host, and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction“

Prof. Tuckermann, Jan (21.07.2015)
Universität Ulm
„Modes of GR action reversed: Synergistic Gene Induction limits Inflammation and Gene Repression affects Bone“

Dr. Turner, Martin (01.12.2009)
The Babraham Institute, Cambridge, UK
„Roles for RNA binding proteins during lymphocyte development and activation“

Prof. Tüting, Thomas  (10.04.2018)
Universitätsklinikum der Otto-Von-Guericke-Universität Magdeburg
„The role of neutrophils in melanoma pathogenesis and resistance to immunotherapy“

Prof. Tybulewicz, Victor (04.11.2014)
MRC National Institute for Medical Research, London, UK
„Signals controlling B cell survival and T cell adhesion“


Dr. Uderhardt, Stefan (22.05.2019)
Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, NIH, USA
“Effectors vs Protectors: How Anti-Inflammatory Tissue Macrophages Maintain Tissue Homeostasis”

PD Dr. Utermöhlen, Olaf (12.01.2010)
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene der Universität Köln
„Saure Sphingomyelinase im Immunsystem“


Dr. van der Burg, Sjoerd (26.01.2010)
Leiden University Medical Center, The Netherlands
„Immune correlates of success and failure of therapeutic vaccination“

Ph.D. van der Vlag, Johan (26.05.2009)
Nijmegen Centre for Molecular Life Sciences, The Netherlands
„Apoptotic blebs and apoptosis-modified autoantigens: Triggers leading to autoimmunity in Systemic Lupus Erythematosus“

Dr. van de Veerdonk, Frank (31.05.2016)
Radboud University Medical Center, Nijmegen, The Netherlands
„From basic immunology to novel treatment strategies in aspergillosis“

Prof. van Endert, Peter (13.10.2015)
INSERM, Hôpital Necker, Paris, France
„Endosome dynamics and antigen presentation by dendritic cells“

Prof. van Spriel, Annemiek (03.07.2018)
Department of Tumor Immunology, University of Nijmegen, Niederlande
“Tetraspanins: molecular organizers of the immune cell surface”

Prof. Vermeire, Séverine  (12.06.2018)
Department of Gastroenterology, University hospitals Leuven, Belgien
“Novel therapeutic opportunities in IBD and where to place them”

Prof. Veelken, Hendrik (17.05.2011)
Leiden, University Medical Center, The Netherlands
„Mutual Interactions between Malignant Lymphomas And The Immune System: Prospects for Novel Therapeutic Interventions“

Dr. Versteeg, Gijs (03.06.2014)
Max F. Perutz Laboratories (MFPL), Vienna, Austria
„TRIMmunity: The roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity“

Prof. Verweij, Cornelis (11.11.2014)
VU University Medical Center Amsterdam,The Netherlands
„Clinical relevance of tertiary lymph node structures and interferon system in rheumatoid arthritis.“

Prof. Visekruna, Alexander (29.10.2019)
Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Philipps-Universität Marburg
“Regulation of the mucosal immune system by dietary and microbial factors”

Prof. Vivier, Eric (12.04.2013)
Centre d’Immunologie de Marseille-Luminy, Marseille, France
„Natural Killer cells, Innate Lymphoid cells and Innate Imumnity“


Prof. Wagner, Erwin (21.05.2019)
Centro Nacional de Investigaciones, Oncológicas (CNIO), Madrid, Spain
“Innate immune signaling in Inflammatory Skin/Joint Disease and Lung Fibrosis”

Ph.D. Wagner, Samuel (05.11.2013)
Eberhard Karls University Tübingen
„Structure, assembly, and function of a bacterial nanosyringe“

Prof. Wagner, Samuel (08.12.2020)
Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Tübingen
“Assembly, structure, and function of a bacterial nanosyringe”

Prof. Waisman, Ari (02.06.2015)
Institut für Molekulare Medizin, Universitätsmedizin der Johannes Gutenberg-Universität Mainz
„What makes Th17 cells pathogenic?“

Prof. Waisman,, Ari (21.12.2010)
Medizinische Klinik und Poliklinik Universität Mainz
„New murine models to study inflammatory cytokines“

Prof. Walzer, Thierry (20.01.2009)
Centre d’Immunologie Marseille-Luminy, France
„Natural Killer cell development and trafficking“

Dr. Wardemann, Hedda (17.12.2013)
Max Planck Institute for Infection Biology, Berlin
„Single cell analysis of B cell repertoires“

Dr. Waskow, Claudia (28.05.2013)
DFG Center for Regenerative Therapies (CRTD), Dresden
„Opening-up the niche for human and mouse hematopoietic stem cells“

Prof. Watson, Alastair (09.01.2013)
University of East Anglia, Norwich, UK
„Intestinal Inflammation and Barrier Function“

Prof. Weichhart, Thomas (28.06.2016)
Medizinische Universität Wien
„mTOR and macrophage homeostasis“

PD Dr. Weighardt, Heike (12.06.2012)
Leibniz-Institut für umwelt- medizinische Forschung, Düsseldorf
„Interactions between the environment and the innate immune system“

Prof. Weih,, Falk (22.05.2012)
Leibniz-Institut für Altersforschung, Fritz-Lipmann-Institut, Jena
„On T-cell responses in the aortic wall of hyperlipidemic mice and how lymphotoxin signaling regulates adipogenesis“

Prof. Weiss, Sigfried (03.02.2009)
Helmholtz Zentrum für Infektionsforschung, Braunschweig
„Interaction of tumor colonizing bacteria with the immune system“

Prof. Weissman, Irving (11.05.2010)
Stanford University School of Medicine, CA, USA
„Normal and Neoplastic Stem Cell“

Prof. Werner, Ernst (02.02.2016)
Innsbruck Medical University
Center for Chemistry and Biomedicine (CCB)
„Tetrahydrobiopterin: Impact on ischemia-reperfusion injury, allograft rejection and lipid metabolism“

Prof. Wilhelm, Christoph (11.07.2017)
Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn
„Metabolic Regulation of ILC Mediated Barrier Immunity“

PD Dr. Winner, Beate (24.04.2012)
IZKF Nachwuchsgruppe, Universität Erlangen
„Modeling neurodegenerative disease using pluripotent stem cells“

Dr. Winter, Sebastian (03.03.2020)
Department of Microbiology, UT Southwestern Medical Center; Dallas, TX, USA
“Gut Microbiota Metabolism during Health and Disease”


Prof. Wayne M., Yokoyama (22.06.2021)
Washington University Medical Center, St. Louis, MO, USA
“Inhibitory natural killer cell receptors control viral infections”

Dr. Yu, Philipp (19.11.2013)
Institut für Immunologie, Philipps-Universität Marburg, GER
„IgE in Anaphylaxis, but is there a function beyond Allergy?“

Dr. Yuan, Joan (09.06.2020)
Division of Molecular Hematology,
Lund University, Lund, Schweden
“Developmental timing imparts distinct B cell responses in vivo”


Dr. Zaiss, Mario (24.10.2017)
Medizinische Klinik 3, Universitätsklinikum Erlangen, FAU
“Gut bacterial metabolites and inflammatory diseases”

Dr. Zarbock, Alexander (23.02.2010)
Universität Münster
„Die Selektin vermittelte Aktivierung von Leukozyten (Selectin-mediated leukocyte activation)“

Dr. Zehn, Dietmar (21.10.2014)
Centre hospitalier universitaire vaudois (CHUV), Lausanne, Switzerland
„Linking functional diversity and TCR affinity in chronic infections“

Prof. Zehn, Dietmar (01.12.2020)
School of Life Sciences Weihenstephan, Technical University of Munich
“Mechanisms controlling the differentiation of proliferation competent and terminally differentiated cells in acute and chronic infection.”

Prof. Zeiser, Robert (10.11.2015)
Klinik für Innere Medizin I, Universitätsklinikum Freiburg
„Pathomechanisms of intestinal acute GvHD“

Prof. Zeißig, Sebastian (09.07.2019)
Medizinische Klinik I – Universitätsklinikum Dresden
„Calcineurin and NFAT in the regulation of intestinal tumor development“

Prof. Zenke, Martin (04.12.2018)
Helmholtz Institute for Biomedical Engineering, Uniklinik Aachen, RWTH
“iPS cells for studying DC and leukemia”

Prof. Zielinski, Christina (14.06.2016)
Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München
„Regulation of human T helper cell subsets by the microenvironment in health and disease“

Prof. Zippelius, Alfred (30.05.2017)
Department of Biomedicine, University Hospital Basel, Schweiz
„Cancer Immunotherapy: Strategies for personalization and combination approaches“

Prof. Zitvogel, Laurence (20.07.2010)
Institut Gustave Roussy, Villejuif, Paris, France
„How can chemotherapy represent an authentic cancer vaccine?“